Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P050023/S214

Acticor Sky HF-T, Rivacor Sky HF-T, Rivacor Rise HF-T, Rivacor Aura HF-T, Acticor Sky HF-T QP, Rivacor Sky HF-T QP, Riva

Biotronik, Inc. · Decision date Sep 25, 2026

MEDTECHLEDGER EXPLANATIONP050023/S214

What did the FDA decide?

The FDA record lists P050023/S214 as a 30-Day Notice with an OK30 decision on 2026-09-25, submitted by Biotronik, Inc. Its stated purpose is "to update manufacturing processes for high voltage capacitors in ICDs and CRT-Ds." The supplement reason field is "Process Change - Manufacturer/Sterilizer/Packager/Supplier." The devices are grouped under product code MRM, defibrillator, implantable, dual-chamber, in Cardiovascular. Because the number carries the P050023 root, it is a supplement to that premarket approval rather than a separate original PMA or an approval of the full system.

The notice identifies high voltage capacitors as the changed component but gives no detail on the prior process, the replacement process, supplier identity, the ICD and CRT-D models affected, or any validation data. The OK30 decision and the stated purpose indicate a manufacturing process change; they do not independently establish safety or clinical effectiveness, and the record adds no indication, trial, or performance information. Those specifics are absent from the supplied fields.

FDA approval order statement

to update manufacturing processes for high voltage capacitors in ICDs and CRT-Ds
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Sep 25, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P050023/S214
Regulatory pathway
PMA supplement
Product code
MRM
Decision code
OK30
Decision date
Sep 25, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: DEFIBRILLATOR, IMPLANTABLE, DUAL-CHAMBER.

Product code
MRM
FDA device class
3

For the original device and its historical approval scope, see PMA P050023. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P050023 · Original PMA

    TUPOS LV/ATX & KRONOS LV-T CRT-D & COROX OWT STEROID LV PACING LEAD

  2. P050023/S214 received

    Application receipt date recorded by FDA.

  3. P050023/S211 · Related supplement

    PSW 2601.U, NEO 2601.U, Acticor Sky HF-T, Rivacor Sky HF-T, Rivacor Rise HF-T, Rivacor Aura HF-T, Acticor Sky HF-T QP, R

  4. P050023/S204 · Related supplement

    Ilivia 7 VR-T DX 404624; Intica 7 VR-T DX 404633; Intica 5 VR-T DX 404688; Ilivia 7 VR-T 404625; Intica 7 VR-T 404634; I

  5. P050023/S214 · FDA decision

    30-Day Notice

  6. P050023/S213 · Related supplement

    Acticor Sky HF-T 481986; Rivacor Sky HF-T 481991; Rivacor Rise HF-T 482017; Rivacor Aura HF-T 482013; Acticor Sky HF-T Q

  7. P050023/S215 · Related supplement

    Ilivia 7 VR-T DX DF-1 ProMRI Ilivia 7 VR-T DF-1 ProMRI Ilivia 7 VR-T DF4 ProMRI Intica 7 VR-T DX DF-1 ProMRI Intica 7 VR

  8. P050023/S216 · Related supplement

    Ilivia 7 VRT DX, Intica 7 VRT DX, Intica 5 VRT DX, Ilivia 7 VRT, Intica 7 VRT, Intica 5 VRT, Inlexa 7 VRT, Inlexa 7 VRT

Timeline entries are records held by MedtechLedger for P050023. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P050023

Explore the linked device profile

Other records with product code MRM

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Biotronik, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
6024 Jean Rd., Lake Oswego, OR, 97035

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records